A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This is a phase 1 study evaluating ziftomenib in combination with azacitidine and venetoclax, or standard induction therapy cytarabine/daunorubicin (7+3) or vyxeos chemotherapy for patients who have newly diagnosed or relapse refractory acute myeloid leukemia with KMT2A rearrangement or NPM1 mutation.